Comparative Study of UV And HPLC Methods for Estimation of Drug

Abstract

Pharmaceutical analysis is a cornerstone of drug quality, ensuring identity, purity, safety, and efficacy across the drug lifecycle. Analytical method development and validation are essential for detecting and quantifying pharmaceutical compounds, monitoring impurities, and supporting regulatory compliance. Techniques such as UV spectroscopy and high-performance liquid chromatography (HPLC) remain widely used, with each offering unique advantages and limitations. Method validation parameters—including accuracy, precision, specificity, linearity, robustness, and sensitivity—ensure reliability and reproducibility. Recent advances like UHPLC, LC–MS/MS, diode-array detection, and green analytical approaches have further improved analytical efficiency and sustainability. Despite these innovations, challenges persist in terms of method selection, sensitivity, cost, regulatory compliance, and environmental concerns. Future directions emphasize quality by design (QbD), real-time analytical technologies, computational tools, and miniaturized portable devices, all of which aim to create faster, greener, and more robust analytical methods for pharmaceutical applications.

Keywords

Comparative study, UV, HPLC methods, estimation of Drug

Introduction

Image: UV spectroscopy

Benefits:

• Great specificity and sensitivity
• Can distinguish and quantify complex mixtures
• Good for many different types of samples
• Can be connected to a variety of detectors, such as fluorescence, MS, and UV.

Restrictions:

• • demands expensive machinery and upkeep
  • The process of creating and validating time-consuming methods
  • Need qualified workers

• • Instances
  • Measuring the quantity of oseltamivir in medicinal preparations
  • Calculating the quantities of nevirapine, lamivudine, and stavudine in tablets

Examining remdesivir in various pharmaceutical formulations- Use cases:

• • Complex sample analysis
  • Separation and quantification of multi-component samples
• Stability-indicating studies [5-6]

parameters for validating a method

Prior to the creation of analytical methods, method validation is an essential step that ensures the method is appropriate for its intended use. The following parameters are usually assessed during method validation:

1. Specificity and Selectivity

- When the moment comes. Specificity: The capacity of the method to identify the analyte of interest in the presence of other substances.

- The method's selectivity is its capacity to differentiate between the analyte of interest and other compounds.

- At the conclusion of the session Importance: Makes sure the technique is able to measure the analyte accurately without being affected by other elements.

2. Linearity and Scope

- Linearity: The methodology's capacity to generate results that are precisely proportionate to the concentration of the analyte.

- Range: The concentration range in which the technique is linear.

- Importance: Guarantees the method's ability to precisely quantify the analyte across a spectrum of concentrations.3. Accuracy and Recovery Studies

3. Accuracy: The degree of proximity between the measured value and the real value.

- Recovery studies: Experiments that assess the method's ability to extract the analyte from a sample.

- Significance: Verifies that the analyte may be measured by the technique with precision.

4. Accuracy (Intermediate Precision, Repeatability)

- Precision: The extent to which repeated measurements concur.

- When Repeatability: The method's accuracy under the same circumstances.

- Intermediate precision: The technique's accuracy across a range of circumstances (e.g., different analysts, instruments).

- Importance: Guarantees the approach will yield consistent outcomes.

5. 5. LOD and LOQ

- LOD (Limit of Detection): The lowest concentration of the analyte that may be found.

 LOQ (Limit of Quantitation): The lowest amount of the analyte that may be measured quantitatively.

Importance: Makes certain that the approach can identify and measure the analyte even at low levels.

5. 6. Resilience and Durability

In a moment, the car will start. Resilience: The method's capacity to withstand minor adjustments to its parameters.

Robustness: The technique's resilience to variations in environmental factors.

 Significance: Guarantees that the method will produce consistent outcomes across varied settings.

5. 7. Testing System Suitability (SST)

SST: A test that determines if the analytical system is appropriate for the application.

 Importance: Makes certain that the analytical system is operating as it should and is capable of generating trustworthy results. [15–16-17-18]

Recent developments and hybrid strategies

In recent years, HPLC techniques have advanced, leading to notable improvements in the detection, identification, and quantification of process-related contaminants and degradants in medications. Some notable advancements are: 1

• Ultra-High-Performance Liquid Chromatography (UHPLC): Offers superior resolution and sensitivity for improved separation of complex mixtures.
• LC-MS/MS: Combines the separation capabilities of liquid chromatography with the sensitivity of mass spectrometry, providing improved trace impurity detection and identification.
• High-Resolution Mass Spectrometry (HRMS): Facilitates the accurate quantification of analytes and full structural determination.
• Diode-Array Detection (DAD): Improves the identification and quantification of analytes based on how well they absorb ultraviolet and visible light.
• Innovations in Photodiode Array (PDA) detection and Diode Array Detection (DAD)
• Spectral data from DAD and PDA detectors allow for the identification of analytes and the evaluation of peak purity.These detectors have greater sensitivity and selectivity for a variety of contaminants.

5. Green Analytical Chemistry Methods
5.  Eco-friendly solvents: The use of greener solvents minimizes environmental effect while enhancing impurity profiling and regulatory compliance.
5. Little HPLC systems: These systems make HPLC more ecologically friendly by using less solvent and producing less waste.
5.  Improving UV methods to reduce waste: By optimizing UV detection methods, waste production can be minimized and the environmental impact of analytical methods can be lessened.
5. UV and HPLC Hybrid Methods

HPLC-UV: Combines the separation capabilities of HPLC with the sensitivity of UV detection, allowing for the identification and quantification of analytes.

HPLC-DAD: Combines HPLC with DAD, increasing analyte identification and quantification by providing spectral data. [7-8-9]

The Obstacles to Creating Methods

Due to a number of reasons, it might be difficult to develop methods for pharmaceutical analysis. Among the main obstacles are:

1. Choosing the Right Method

Selecting among chromatographic (HPLC, GC, UPLC), spectroscopic (UV, IR, NMR), or other analytical approaches. Maintaining a balance between cost, speed, specificity, and sensitivity.

2. Issues Related to Samples

The drug or analyte has low solubility. Instability (light, heat, or pH-sensitive compounds). Interference from excipients, contaminants, or biological matrices.

3. Sensitivity & Specificity

Ensuring that the procedure can detect very low concentrations (LOD, LOQ). Distinguishing the analyte from isomers, degradants, or closely related chemicals.

4. Problems with Method Validation

The adherence to regulatory standards (ICH, USP, FDA guidelines). Showing precision, accuracy, linearity, robustness, and reproducibility.

5. Technical and instrumental restrictions

Maintaining and calibrating instruments. In methods like LC-MS/MS, there are matrix effects. sssNot all analytes have universal detectors

5. 6. Time and Financial Constraints

Creating a technique that is both dependable and affordable. Between comprehensive optimization and rapid outcomes, there must be a balance.

5. 7. Problems with Rules and Compliance

Bringing procedures into compliance with pharmacopeial standards. reproducibility issues with the transfer of methods between labs. Requirements for audit and documentation.

5. 8. Considerations for the Environment and Safety

The use of hazardous solvents such acetonitrile and chloroform. necessities for waste disposal and sustainability (green analytical chemistry).

5. 9. Analyte complexity

Multicomponent formulas. The enantiomers are separated via chiral separation.large biomolecules (proteins, peptides, antibodies) that need sophisticated approaches. [10]

5. Interference from excipients in formulations
5. Interference from excipients: It can be difficult to create a robust method because excipients in pharmaceutical formulations can interfere with the examination of active pharmaceutical components (APIs).
5. - Method development should take into account the quantity and kind of excipients in the formulation. Approaches like HPLC can be improved upon to separate APIs from excipients.

1. The symbol for this is a circle.
2. The stability of drugs during analysis
3. Drug stability: The accuracy and precision of drug analysis can be impacted by the fact that some drugs are unstable.
4. The stability of the medication during analysis should be taken into account during method development. Drug degradation can be minimized by optimizing methods like HPLC.
5. The sign reads as follows:

5.  Regulatory Documentation Obstacles
5.  Regulatory requirements: Regulatory bodies often demand a lot of documentation for method validation, which may be both time-consuming and complicated.

1. - Method development should follow regulatory standards, and documentation should be complete and precise, according to the solution.
2. Methods are transferable between labs.
3. Method transferability: Due to variations in equipment, staff, or environmental circumstances, methods created in one lab may not be transferable to another.
4. The solution is to assess the transferability of methods during their development and validate them for use in a variety of labs. [11-12-13-14]

5. FUTURE PERSPECTIVES

1. Quality by Design (QbD)-Based Method Development

Focus on understanding method variables (critical method parameters, CMAs) and their impact on method performance. Uses risk assessment and Design of Experiments (DoE) for robust methods.

1. Analytical Chemistry (GAC) that is Green

The development of environmentally friendly techniques that use less hazardous solvents, produce less waste, and are energy efficient.

2.Example: using supercritical fluid chromatography, water-based chromatography, and miniaturized devices

3. Sophisticated & Hyphenated Methods

CE–MS, LC–NMR, GC–MS, and LC–MS/MS for increased sensitivity and selectivity. multidimensional chromatography (2D-LC) for complicated mixtures.

4. High-throughput screening and automation (HTS)

robot-based systems for quick sample preparation and analysis. Parallel testing of many conditions for quicker technique optimization.

5. Real-Time Analytical Technologies (PAT & RTRT)

real-time monitoring during production using Process Analytical Technology (PAT). The need for end-product testing is lessened by Real-Time Release Testing (RTRT).

6. Methods Using Computers and In Silico

Utilizing chemometrics, machine learning, and artificial intelligence to forecast chromatographic behavior, improve conditions, and lessen trial-and-error.

7. Smaller size & portable devices

The creation of lab-on-a-chip devices based on microfluidics. Handheld spectroscopic instruments (Raman, NIR) for use in on-site and field testing.

8. Management of the Analytical Method Life Cycle (AMLM)

Ongoing surveillance, re-validation, and revision of analytical methodologies during the course of a product's lifespan. Prioritize the transferability of methods between labs. Emphasis on method transferability between labs. Future perspectives in pharmaceutical analysis are evolving rapidly, driven by advances in technology and the need for more efficient, sustainable, and accurate methods. Some key trends include:

• Integration with Chemometric Analysis: Chemometrics, a field that combines chemical data analysis with statistical and mathematical techniques, is increasingly being integrated with analytical methods like HPLC and UV spectroscopy. This integration enables researchers to extract more meaningful insights from complex data sets, improving the analysis of pharmaceutical compounds.
• Development of Rapid, Portable UV and HPLC Devices: Portable analytical devices are being developed to enable rapid, on-site analysis of pharmaceuticals. These devices can provide real-time results, improving the efficiency of pharmaceutical analysis and enabling faster decision-making.
• Artificial Intelligence in Method Optimization: Artificial intelligence (AI) and machine learning (ML) are being applied to optimize analytical methods, such as HPLC and UV spectroscopy. AI can help predict optimal experimental conditions, reducing the time and resources required for method development.
• Trends toward Sustainable "Green" Methods: There is a growing trend toward developing sustainable and environmentally friendly analytical methods. This includes the use of eco-friendly solvents, miniaturized HPLC systems, and UV method optimization to reduce waste. Green analytical chemistry aims to minimize the environmental impact of analytical techniques while maintaining their effectiveness.
• Some specific examples of these trends include:
• HPLC-UV Method Development: Researchers have developed HPLC-UV methods for monitoring the synthesis of active pharmaceutical ingredients (APIs) and quantifying pharmaceutical compounds in various matrices.
• Stability-Indicating HPLC Methods: Stability-indicating HPLC methods have been developed for analyzing pharmaceutical compounds, enabling the detection of degradation products and impurities.
• UV Spectroscopy: UV spectroscopy is being used for the quantification of pharmaceutical compounds, offering a simple and rapid analytical technique. [19-20-21]

CONCLUSION

Analytical method development and validation are vital for ensuring the quality and safety of pharmaceutical products. While traditional techniques like UV spectroscopy and HPLC continue to play a central role, modern advances and regulatory expectations demand more sensitive, accurate, and eco-friendly approaches. The main challenges include balancing cost with performance, ensuring method transferability, and meeting global regulatory standards. Looking ahead, the integration of QbD, artificial intelligence, real-time monitoring, and sustainable practices will reshape the future of pharmaceutical analysis, leading to more efficient and reliable methods that support drug innovation and patient safety.

REFERENCE

1. More SS, Kadam SP, Redasani VK. A review on analytical method development and validation. Int J Pharm Res Appl. 2025;10(1):1177-1195. Available from: www.ijprajournal.com
2. Sharma S, Goyal S, Chauhan K. A review on analytical method development and validation. Int J Appl Pharm. 2018;10(6):8-15.
3. Bhenjaliya H, Barse R. Analytical method development and validation: Requirements in pharmaceutical field. Manipal J Pharm Sci. 2020;6(1):1-6.
4. Sirajunisa T, Umme H. Spectrophotometric methods in pharmaceutical analysis: Principles, reagents, and applications. Int J Environ Sci Nat Res. 2024;34(4):556391. doi:10.19080/IJESNR.2024.34.556391
5. Somkuwar et al. Comparative study of UV spectroscopy, RP-HPLC, and HPTLC methods for quantification of lamivudine in tablet formulation. 2024.
6. Gungor et al. Comparison of HPLC and UV spectrophotometric methods for oseltamivir quantification in pharmaceutical formulations. 2022.
7. Reddy PC, et al. Advancements in HPLC techniques for detecting and identification of process-related and degradant impurities in pharmaceutical compounds. Int J Pharm Sci. 2025
8. Sunkara B, Tummalapalli NV. Development of novel gradient RP-HPLC method for separation of dapagliflozin and its process-related impurities. Future J Pharm Sci. 2023;9(107).
9. Pathak S, Mishra P. Stability-indicating HPLC-DAD method for the determination of empagliflozin. Future J Pharm Sci. 2021;7(181).
10. Sajonz P, Wu Y, Natishan TK, McGachy NT, DeTora D. Challenges in the analytical method development and validation for an unstable active pharmaceutical ingredient. J Chromatogr Sci. 2006;44(3):132-140. doi:10.1093/chromsci/44.3.132
11. Challenges in analytical method development and validation. J Pharm Sci. 2020.
12. Method development and validation for pharmaceutical analysis. Google Scholar. 2019.
13. Transferability of analytical methods between laboratories. PubMed. 2018.
14. Regulatory requirements for analytical method validation. ScienceDirect. 2022.
15. Method validation in pharmaceutical analysis. J Pharm Sci. 2020.
16. Validation of analytical methods: A review. Google Scholar. 2019.
17. Method validation parameters: A review. PubMed. 2018.
18. System suitability testing: A review. ScienceDirect. 2022.
19. Somkuwar et al. Comparative study of UV spectroscopy, RP-HPLC, and HPTLC methods for quantification of antiviral drug lamivudine in tablet formulation. 2024.
20. Tesoro et al. Development and validation of a reversed-phase HPLC method with UV detection for the determination of L-Dopa in Vicia faba L. broad beans. 2022.
21. Anbazhagan et al. Simultaneous quantification of stavudine, lamivudine, and nevirapine by UV spectroscopy, reverse phase HPLC, and HPTLC in tablets. 2005.
22. Ultraviolet–visible spectroscopy [Internet]. Wikipedia. Available from: https://en.wikipedia.org/wiki/Ultraviolet%E2%80%93visible_spectroscopy.